Immunotherapies in Treatment of Bladder Cancer

Reactions to the emergence of novel immunotherapy agents for treatment of bladder cancer, including increased administration in community urology practices, and recommendations for sequencing newer therapies into treatment algorithms.

EP1: Incidence and Typical Characteristics of Newly Diagnosed Bladder Cancer

January 14th 2022

The current incidence of bladder cancer diagnoses and most common symptoms that newly diagnosed patients present with.

EP2: Treatment Journey for a Patient With Bladder Cancer

January 14th 2022

The types of healthcare professionals who may play a role in evaluating and diagnosing bladder cancer.

EP3: Treating Bladder Cancer in Community Settings

January 21st 2022

Administration of systemic therapy and management of side effects in patients with bladder cancer.

EP4: Multidisciplinary Care in Bladder Cancer

January 21st 2022

Elements that are critical to ensuring that patients with bladder cancer are managed appropriately by various healthcare professionals who will likely interact with patients and their family throughout the cancer journey.

EP5: Support Resources for Patients With Bladder Cancer

February 9th 2022

Types of educational resources available to support patients with bladder cancer as recommended by urologists and medical oncologists.

EP6: Current Treatment Guidelines for Bladder Cancer

February 9th 2022

An overview of treatment guidelines available to support urologists and medical oncologists who manage patients with bladder cancer.

EP7: Frontline Therapy for Non-Metastatic Muscle-Invasive Bladder Cancer

February 16th 2022

Frontline treatment approaches recommended by urologists and medical oncologists for patients with non-metastatic muscle-invasive bladder cancer.

EP8: High-Risk Non-Muscle Invasive Bladder Cancer: Frontline Therapy

February 16th 2022

First-line treatment options available for patients with high-risk non-muscle invasive bladder cancer and variables that affect treatment decisions.

EP9: Emerging Novel Therapies for Nonmetastatic Muscle Invasive Bladder Cancer

February 23rd 2022

The role of adjuvant therapy in nonmetastatic muscle invasive bladder cancer, and an overview of promising novel therapies in the treatment pipeline.

EP10: Active Surveillance in Muscle Invasive Bladder Cancer

February 23rd 2022

Types of patients with muscle invasive bladder cancer who may be candidates for a watch-and-wait approach.